1. Home
  2. GRFS vs AVAV Comparison

GRFS vs AVAV Comparison

Compare GRFS & AVAV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GRFS
  • AVAV
  • Stock Information
  • Founded
  • GRFS 1940
  • AVAV 1971
  • Country
  • GRFS Spain
  • AVAV United States
  • Employees
  • GRFS N/A
  • AVAV N/A
  • Industry
  • GRFS Biotechnology: Pharmaceutical Preparations
  • AVAV Aerospace
  • Sector
  • GRFS Health Care
  • AVAV Industrials
  • Exchange
  • GRFS Nasdaq
  • AVAV Nasdaq
  • Market Cap
  • GRFS 7.2B
  • AVAV 12.1B
  • IPO Year
  • GRFS 2006
  • AVAV 2007
  • Fundamental
  • Price
  • GRFS $9.80
  • AVAV $266.93
  • Analyst Decision
  • GRFS Hold
  • AVAV Strong Buy
  • Analyst Count
  • GRFS 1
  • AVAV 12
  • Target Price
  • GRFS $10.30
  • AVAV $288.17
  • AVG Volume (30 Days)
  • GRFS 526.8K
  • AVAV 982.9K
  • Earning Date
  • GRFS 01-01-0001
  • AVAV 09-09-2025
  • Dividend Yield
  • GRFS 1.45%
  • AVAV N/A
  • EPS Growth
  • GRFS 132.60
  • AVAV N/A
  • EPS
  • GRFS 0.53
  • AVAV N/A
  • Revenue
  • GRFS $8,744,226,659.00
  • AVAV $1,085,820,000.00
  • Revenue This Year
  • GRFS $6.00
  • AVAV $149.08
  • Revenue Next Year
  • GRFS $6.71
  • AVAV $15.36
  • P/E Ratio
  • GRFS $24.77
  • AVAV N/A
  • Revenue Growth
  • GRFS 9.32
  • AVAV 44.03
  • 52 Week Low
  • GRFS $6.19
  • AVAV $102.25
  • 52 Week High
  • GRFS $11.14
  • AVAV $295.90
  • Technical
  • Relative Strength Index (RSI)
  • GRFS 45.13
  • AVAV 63.35
  • Support Level
  • GRFS $9.63
  • AVAV $225.75
  • Resistance Level
  • GRFS $10.06
  • AVAV $257.07
  • Average True Range (ATR)
  • GRFS 0.18
  • AVAV 11.06
  • MACD
  • GRFS -0.02
  • AVAV 3.60
  • Stochastic Oscillator
  • GRFS 32.31
  • AVAV 94.84

About GRFS Grifols S.A.

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

About AVAV AeroVironment Inc.

AeroVironment Inc operates under a single business segment in which it supplies unmanned aircraft systems, tactical missile systems, high-altitude pseudo-satellites, and other related services to government agencies within the United States Department of Defense as well as the United States allied international governments. The systems can help with security, surveillance, or sensing, and provide eyes in the sky without needing an actual person, or driver in the sky. The company is a defense technology provider delivering integrated capabilities across air, land, sea, space, and cyber. It develops and deploy autonomous systems, precision strike systems, counter-UAS technologies, space-based platforms, directed energy systems, and cyber and electronic warfare capabilities.

Share on Social Networks: